Kadant Inc (KAI) 50.64 $KAI Illinois Tool's Growth

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Kadant Inc (KAI) 50.64 $KAI

Illinois Tool's Growth Potential Solid, Runs Near-Term Risks
Zacks Equity Research - Zacks Investment Research - 45 mins ago
We issued an updated research report on Illinois Tool Works Inc. (ITW) on Jun 10, 2016.
KAI: 50.64 (-0.32), GRC: 29.40 (-0.91), LXFR: 11.97 (-0.43), ITW: 108.09 (-0.71)

Dover To Buy Wayne Fueling, Expands in Global Retail Fueling
Zacks Equity Research - Zacks Investment Research - Fri Jun 10, 8:13AM CDT
Dover Corporation (DOV) is acquiring Wayne Fueling Systems Ltd. from Riverstone Holdings LLC, for $780 million in cash.
NDSN: 84.88 (-2.08), KAI: 50.64 (-0.32), GRC: 29.40 (-0.91), DOV: 70.67 (-1.41)

Kennametal's Investment Value High on Solid Potential
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 6:30AM CDT
We have issued an updated research report on Kennametal Inc. (KMT) on Jun 7, 2016.
NDSN: 84.88 (-2.08), KMT: 24.11 (-0.81), KAI: 50.64 (-0.32), GRC: 29.40 (-0.91)

Colfax's Organic Prospects Solid, Near-Term Risks Remain
Zacks Equity Research - Zacks Investment Research - Tue Jun 07, 8:29AM CDT
We have issued an updated research report on Colfax Corporation (CFX) on Jun 7, 2016.
NDSN: 84.88 (-2.08), KAI: 50.64 (-0.32), CFX: 27.87 (-1.01), GRC: 29.40 (-0.91)

Ingersoll (IR) Shows Promise for Healthy Long-Term Growth
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 8:53AM CDT
On Jun 6, Zacks Investment Research updated the research report on Ingersoll-Rand Plc (IR).
KAI: 50.64 (-0.32), IR: 64.49 (-1.20), GRC: 29.40 (-0.91), LXFR: 11.97 (-0.43)

Uptrend Call Working As Kadant Stock Rises 30.0% (KAI)
Comtex SmarTrend(R) - Fri Jun 03, 1:21PM CDT
SmarTrend identified an Uptrend for Kadant (NYSE:KAI) on January 29th, 2016 at $38.15. In approximately 4 months, Kadant has returned 30.02% as of today's recent price of $49.61.
KAI: 50.64 (-0.32)

What Drove Illinois Tool Works to a New 52-Week High?
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 7:21AM CDT
Shares of Illinois Tool Works Inc. (ITW) reached a new 52-week high of $106.75 during its trading session on Jun 1. This apex improved upon the last 52-week high of $106.19 on Apr 19.
KAI: 50.64 (-0.32), GRC: 29.40 (-0.91), LXFR: 11.97 (-0.43), ITW: 108.09 (-0.71)

Luxfer Holdings (LXFR) Now a Strong Buy: Should You Add?
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 6:56AM CDT
Zacks Investment Research upgraded Luxfer Holdings PLC (LXFR) to a Zacks Rank #1 (Strong Buy) on Jun 2.
NDSN: 84.88 (-2.08), KAI: 50.64 (-0.32), GRC: 29.40 (-0.91), LXFR: 11.97 (-0.43)

Gorman-Rupp (GRC) Looks Good: Stock Adds 6.3% in Session
Zacks Equity Research - Zacks Investment Research - Wed Jun 01, 7:00AM CDT
Gorman-Rupp Co. (GRC) was a big mover last session, as the company's shares rose over 6% on the day.
KAI: 50.64 (-0.32), GRC: 29.40 (-0.91)

Is This the Right Time to Buy RBC Bearings (ROLL) Stock?
Zacks Equity Research - Zacks Investment Research - Tue May 31, 7:55AM CDT
On May 30, 2016, Zacks Investment Research upgraded RBC Bearings Inc. (ROLL) to a Zacks Rank #2 (Buy) from a Zacks Rank #3 (Hold).
KAI: 50.64 (-0.32), GRC: 29.40 (-0.91), LXFR: 11.97 (-0.43), ROLL: 74.03 (-1.47)

RBC Bearings (ROLL) Beats on Q4 Earnings and Revenues
Zacks Equity Research - Zacks Investment Research - Fri May 27, 9:24AM CDT
Premium machine tools & accessories company RBC Bearings Inc. (ROLL) reported strong results for fourth-quarter fiscal 2016.
KAI: 50.64 (-0.32), GRC: 29.40 (-0.91), LXFR: 11.97 (-0.43), ROLL: 74.03 (-1.47)

Kadant Has Returned 28.3% Since SmarTrend Recommendation (KAI)
Comtex SmarTrend(R) - Fri May 27, 12:56AM CDT
SmarTrend identified an Uptrend for Kadant (NYSE:KAI) on January 29th, 2016 at $38.15. In approximately 4 months, Kadant has returned 28.27% as of today's recent price of $48.94.
KAI: 50.64 (-0.32)

Middleby (MIDD) Upgraded to Buy on Strong Growth Drivers
Zacks Equity Research - Zacks Investment Research - Tue May 24, 9:28AM CDT
On Mar 23, 2016, Zacks Investment Research upgraded Middleby Corp. (MIDD) to a Zacks Rank #2 (Buy) from a Zacks Rank #3 (Hold).
KAI: 50.64 (-0.32), MIDD: 124.54 (-1.53), GRC: 29.40 (-0.91), LXFR: 11.97 (-0.43)

IDEX (IEX) Shows Promise with Opportune Acquisitions
Zacks Equity Research - Zacks Investment Research - Tue May 24, 6:35AM CDT
On May 24, Zacks Investment Research updated the research report on industrial goods manufacturer IDEX Corporation (IEX).
IEX: 85.94 (-0.88), KAI: 50.64 (-0.32), GRC: 29.40 (-0.91), LXFR: 11.97 (-0.43)

Uptrend Call Working As Kadant Stock Rises 25.1% (KAI)
Comtex SmarTrend(R) - Thu May 19, 1:39PM CDT
SmarTrend identified an Uptrend for Kadant (NYSE:KAI) on January 29th, 2016 at $38.15. In approximately 4 months, Kadant has returned 25.15% as of today's recent price of $47.75.
KAI: 50.64 (-0.32)

Kadant Authorizes Share Repurchase
BusinessWire - Wed May 18, 4:20PM CDT
Kadant Inc. (NYSE:KAI) announced today that its board of directors has authorized the repurchase of up to an additional $20 million of its equity securities effective May 18, 2016 through May 18, 2017. Repurchases may be made in public or private transactions, including under Securities Exchange Act Rule 10b-5-1 trading plans. The timing and amount of any repurchases will be at the discretion of Company management and will be based on market conditions and other considerations, including limitations contained in our credit agreement entered into on August 3, 2012. Through May 18, 2016, under the existing $20 million authorization that will expire on May 20, 2016, the Company has repurchased 143,242 shares of its common stock for an aggregate purchase price of approximately $5.9 million, or an average of $40.95 per share.
KAI: 50.64 (-0.32)

Kadant Declares Cash Dividend
BusinessWire - Wed May 18, 4:13PM CDT
Kadant Inc. (NYSE:KAI) announced that its board of directors has approved a quarterly cash dividend to stockholders of $0.19 per share to be paid on August 11, 2016 to stockholders of record as of the close of business on July 14, 2016. Future declarations of dividends are subject to Board approval and may be adjusted as business needs or market conditions change.
KAI: 50.64 (-0.32)

IDEX Subsidiary to Acquire AWG for Higher Inorganic Growth
Zacks Equity Research - Zacks Investment Research - Tue May 17, 6:59AM CDT
LUKAS Hydraulik GmbH, a subsidiary of IDEX Corporation (IEX), recently inked a definitive agreement to acquire German firm AWG Fittings GmbH for ???46 million.
IEX: 85.94 (-0.88), KAI: 50.64 (-0.32), GRC: 29.40 (-0.91), LXFR: 11.97 (-0.43)

Kadant Shares Up 26.0% Since SmarTrend's Buy Recommendation (KAI)
Comtex SmarTrend(R) - Thu May 12, 1:02AM CDT
SmarTrend identified an Uptrend for Kadant (NYSE:KAI) on January 29th, 2016 at $38.15. In approximately 3 months, Kadant has returned 25.96% as of today's recent price of $48.06.
KAI: 50.64 (-0.32)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 41

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 36

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 32

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 37

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Growth of Middle-Class Investors through Mutual Fund Ownership

Updated Category News Views 149

Mutual Funds and the Rise of the Middle-Class Investor Over recent years, mutual fund ownership has surged among middle-class families. According to insights from the Investment Company Institute (ICI), this trend signifies a vital transition as middle-income households increasingly seek investment opportunities. The growing presence of mutual funds in the American...

Continue Reading
Rques Exchange Reinforces Its Brand with Compliance Strategy

Updated Category News Views 180

Rques Exchange Reinforces Brand with Regulatory Frameworks Rques Exchange is taking significant steps to enhance its brand by emphasizing its commitment to regulatory alignment, operational transparency, and governance integrity in various markets. With global authorities increasingly scrutinizing digital asset platforms, Rques aims to position itself as a technology...

Continue Reading
Business Growth and Confidence: Provident Bank's Insights

Updated Category News Views 120

Increasing Business Confidence for the Future Recently, Provident Bank, a prominent financial institution based in New Jersey, conducted an enlightening Economic Outlook survey. This survey reflects the sentiments of 1,000 business leaders regarding the 2025 economic prospects. The results showcase a robust sense of optimism and confidence among businesses as they look...

Continue Reading
Performance Food Group Co: A Five-Year Stock Journey

Updated Category News Views 219

Unlocking the Value of Investment in Performance Food Group Co Performance Food Group Co (NYSE: PFGC) has delivered impressive returns over the last five years, standing out in the competitive market landscape. With an annualized return that has surpassed the market by 9.42%, investors have seen an average growth rate of around 24.5%. This stock is not just another entry...

Continue Reading
Understanding Rathbones Group Plc's Disclosure Requirements

Updated Category News Views 227

Key Information on Disclosure Requirements Understanding how companies disclose their shareholding is crucial for investors and stakeholders alike. Rathbones Group Plc plays an essential role in managing these disclosures, particularly regarding relevant securities that represent substantial interests in listed companies. Full Name of the Discloser The full name of the...

Continue Reading